We offer a wide variety of skincare products to address all of your skincare needs. Ask Dr. Smith or a dedicated staff member for their recommendations for your skin.
For your convenience, we now offer a online store to purchase items from.
Dr. Smith can treat a wide variety of skin conditions. Skin conditions treated in our office include, but are not limited to, the following:
The treatment options that a he will recommend will depend on the specific skin condition or growth about which you are concerned. However, some of the most common treatment options include:
Dr. Smith will work with you to choose the treatment option that is best for you and your personal health goals. He will also discuss the risks and benefits of each treatment option so that you can make an informed decision.
As a dermatopathologist, Dr. Smith specializes in diagnosing disorders of the skin under a microscope. These services encompass all dermatologic related disorders.
Dr. Smith understands that waiting for biopsy results can be stressful. At Scheen & Smith, PSC we pride ourselves in prompt and accurate diagnoses. Dr. Smith reads and interprets your biopsy results and then personally calls each patient with the results.
Actinic Keratosis (AK) (plural: Actinic Keratoses, AKs) are premalignant lesions of the skin that, when left untreated, can potentially develop into skin cancer. There are different stages of AK, ranging from mild to severe, with different amounts of scale and color. AKs often occur as multiple lesions on skin areas frequently exposed to the sun, e.g. the face, scalp, neck, ears, arms and hands.
Since the damage caused by frequent sun exposure is accumulated over many years, people in the second half of their life are most frequently affected with actinic keratoses (age 40 and older). The fact that tanning has been very popular for decades has led to an increase in AK with more and more people being affected as they grow older. Sun worshipers are at an increased risk, and even if you have not been sun bathing, outdoor activities such as gardening, walking in the sun, and working outside can cause enough damage that you may be at risk for developing actinic keratoses.
AK is the most frequent precancer. It can potentially develop into squamous cell carcinoma (SCC), the second most common skin cancer, which can become life threatening if untreated and may require surgery. A retrospective study has shown that in up to 10% of AK patients, individual AK lesions progressed to SCC within an average of two years. Therefore, treating AK during the early stages is a safe and effective way of reducing the risk of AK progression to skin cancer.
Photodynamic therapy (PDT) is a highly effective, non-invasive, irradiation-free light therapy to treat Actinic Keratosis (AK). In principle, it uses light and a photosensitizing (i.e. making something sensitive to light) gel or solution. One of these photosensitizing substances is Aminolevulinic Acid (ALA), a naturally occurring precursor of protoporphyrin IX (PpIX), the photoactive (i.e. activated by light) substance. Once inside the cell, ALA is converted into PpIX by a series of enzymatic reactions. PpIX is activated by light in the presence of oxygen, resulting in the elimination of AK cells. Aminolevulinic acid is primarily absorbed by premalignant cells, leaving healthy skin cells mostly intact.
This is a cosmetic procedure and payment must be made at the time of treatment.
Dr. Smith injects a sclerosing solution into the superficial blood vessels in the legs. He DOES NOT inject the deeper varicose veins.
The procedure performed in the office is a cosmetic procedure. Some patients report pain in their legs associated with their veins. Unfortunately, this office has not encountered any insurance company who will accept this symptom as evidence to authorize payment for the treatment of superficial blood vessels with a sclerosing solution.
If you do have pain in your legs and this pain is persistent or severe, Dr. Smith suggests you make an appointment with your internist or family physician to rule-out any underlying medical problem causing the pain.
RISKS FROM THE INJECTIONS INCLUDE BUT ARE NOT LIMITED TO:
Cramping, pain, post sclerotherapy hyperpigmentation (brown-red local discoloration of the treated skin, telangiectatic matting (network of blush like, fine superficial blood vessels surrounding the previously treated area), and skin necrosis (local skin loss/superficial ulcer).